About: medicine

Health 31-10-2017

Greek health minister fumes at pharmaceutical company after drug withdrawal

The Greek ministry of health reacted strongly to the decision of a pharmaceutical company to withdraw a drug from the market for “viability” reasons, saying it will not accept any blackmail.
Health 25-10-2017

Greek government on collision course with pharmaceutical companies over innovative drugs

Several pharmaceutical companies in Greece have threatened to stop supplying the market with innovative drugs and said they could even withdraw existing drugs as a result of an obligatory “discount” imposed by the Greek government and applied retroactively.
Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

EU project hopes to phase out animal-testing

When chemicals are considered too dangerous to be tested on humans, animals have long been the answer to some scientific quandaries. The EU project ToxRisk will act as Europe's flagship for safety assessments that do not require the use of animals. EURACTIV Germany reports.
Development Policy 06-10-2015

Nobel awards discoveries in fighting malaria and roundworm

Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases including malaria and elephantiasis won the Nobel Prize for Medicine on Monday (5 October).
Drugs
Health 18-11-2014

Report: Patients suffer from medicine shortages throughout EU

A new report on medicines shortages experienced in European healthcare systems published on Monday (17 November) by the European Association of Hospital Pharmacists (EAHP) reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines in the EU.
Health 14-11-2014

How we can win the war against lung cancer

?The European Commission must lead the charge in ensuring that lung cancer, an overlooked but deadly killer, is finally given the recognition it needs in order to effectively combat it, writes Mogens Ekelund.
CREDIT[Victor/Flickr]
Health 22-09-2014

France should give doctors bonuses to prescribe generic drugs

France is spending too much money on medicine and needs to promote the use of generic drugs. The French Court of Auditors recommends offering doctors incentives to prescribe cheaper generics to achieve this and capping their prescription budgets.

Council rubber stamps private-public partnerships in biomass, air, energy, electronics, medicine

The European Council Tuesday (5 May), approved the roll out of a series of public private partnerships worth up to €22 billion over the next seven years.
Pills
Health 15-04-2014

Parliament clears €3 billion EU medicines R&D initiative

The European Parliament voted in favour of the second Innovative Medicines Initiative (IMI2) on Tuesday (15 April), a multi-billion Euro research programme run jointly by the European Commission and the pharmaceutical industry.
Trade & Society 27-01-2014

MEPs vote for new public-private scheme for innovative medicines

The European Parliament's committee on industry, research and energy (ITRE) on Friday (24 January) adopted the second public-private joint venture in innovative medicines (IMI2).
Health 17-05-2013

Citizens in poor EU states can’t afford medicines, health promoters say

One of the global financial crisis' consequences has been the lack of access to treatment for millions of Europeans. According to health promoters, alternative solutions to the problem may be the way forward.

A breakthrough in combating rare genetic disorders

Europe can lead the way in developing gene therapies to tackle the growing and persistent problem of previously incurable diseases, with huge potential benefits for both patients and industry. Europe needs to promote cross-border research and facilitate access to these new therapies, argues Aurelio Maggio.
Health 19-02-2013

Vets call for ‘horse passport’ register as meat scandal gallops on

As the horsemeat-dressed-as-beef scandal continues to rock Europe’s food industry, a number of organisations are calling on stricter European regulation, including an EU-wide horse passport register.

Study finds orphan drugs economically viable

Orphan drugs, pharmaceutical agents that are developed specifically to treat rare diseases, have the potential to generate as much lifetime revenue as drugs used for more common health conditions, according to a new study.
 VideoPromoted content

Translating Research to Health Innovation: How can forthcoming legislation pave the way for better care in rare diseases?

Several European Commission 2012 initiatives will impact healthcare innovation. The Horizon 2020 research programme will seek to link the health industry, public sector and academia in new research clusters. A revision to the Directive on Clinical Trials will seek to promote health research and innovation. Meanwhile, the Transparency Directive will ensure that research efforts translate into faster access to much- needed medicines.